BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 16957584)

  • 1. Apoptosis and proliferation markers in diffusely infiltrating astrocytomas: profiling of 17 molecules.
    Liu X; Chen N; Wang X; He Y; Chen X; Huang Y; Yin W; Zhou Q
    J Neuropathol Exp Neurol; 2006 Sep; 65(9):905-13. PubMed ID: 16957584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear factor-kappaB activation and differential expression of survivin and Bcl-2 in human grade 2-4 astrocytomas.
    Angileri FF; Aguennouz M; Conti A; La Torre D; Cardali S; Crupi R; Tomasello C; Germanò A; Vita G; Tomasello F
    Cancer; 2008 May; 112(10):2258-66. PubMed ID: 18327814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression patterns and prognostic significance of inhibitor of apoptosis proteins in adenoid cystic carcinoma and pleomorphic adenoma of lachrymal gland.
    Liao Y; Zeng H; Wang X; Huang Y; Chen N; Ge B; Tang L; Luo Q
    Exp Eye Res; 2009 Jan; 88(1):4-11. PubMed ID: 18955046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and prognostic significance of survivin splice variants in diffusely infiltrating astrocytoma.
    Huang Y; Chen X; Chen N; Nie L; Xu M; Zhou Q
    J Clin Pathol; 2011 Nov; 64(11):953-9. PubMed ID: 21730264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced expression of PDCD5 is associated with high-grade astrocytic gliomas.
    Li H; Wang Q; Gao F; Zhu F; Wang X; Zhou C; Liu C; Chen Y; Ma C; Sun W; Zhang L
    Oncol Rep; 2008 Sep; 20(3):573-9. PubMed ID: 18695908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survivin nuclear labeling index: a superior biomarker in superficial urothelial carcinoma of human urinary bladder.
    Yin W; Chen N; Zhang Y; Zeng H; Chen X; He Y; Wang X; Zhou Q
    Mod Pathol; 2006 Nov; 19(11):1487-97. PubMed ID: 16892011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of survivin in astrocytic tumors: correlation with malignant grade and prognosis.
    Kajiwara Y; Yamasaki F; Hama S; Yahara K; Yoshioka H; Sugiyama K; Arita K; Kurisu K
    Cancer; 2003 Feb; 97(4):1077-83. PubMed ID: 12569609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment and prognostic significance of mitotic index using the mitosis marker phospho-histone H3 in low and intermediate-grade infiltrating astrocytomas.
    Colman H; Giannini C; Huang L; Gonzalez J; Hess K; Bruner J; Fuller G; Langford L; Pelloski C; Aaron J; Burger P; Aldape K
    Am J Surg Pathol; 2006 May; 30(5):657-64. PubMed ID: 16699322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of frizzled 9 in astrocytomas.
    Zhang Z; Schittenhelm J; Guo K; Bühring HJ; Trautmann K; Meyermann R; Schluesener HJ
    Neuropathol Appl Neurobiol; 2006 Dec; 32(6):615-24. PubMed ID: 17083476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tenascin-C expression relates to clinicopathological features in pilocytic and diffuse astrocytomas.
    Maris C; Rorive S; Sandras F; D'Haene N; Sadeghi N; Bièche I; Vidaud M; Decaestecker C; Salmon I
    Neuropathol Appl Neurobiol; 2008 Jun; 34(3):316-29. PubMed ID: 17983425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression patterns of inhibitor of apoptosis proteins in malignant pleural mesothelioma.
    Gordon GJ; Mani M; Mukhopadhyay L; Dong L; Edenfield HR; Glickman JN; Yeap BY; Sugarbaker DJ; Bueno R
    J Pathol; 2007 Mar; 211(4):447-54. PubMed ID: 17253596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring the distinctive biological characteristics of pilocytic and low-grade diffuse astrocytomas using microarray gene expression profiles.
    Rorive S; Maris C; Debeir O; Sandras F; Vidaud M; Bièche I; Salmon I; Decaestecker C
    J Neuropathol Exp Neurol; 2006 Aug; 65(8):794-807. PubMed ID: 16896313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced TSC2 RNA and protein in sporadic astrocytomas and ependymomas.
    Wienecke R; Guha A; Maize JC; Heideman RL; DeClue JE; Gutmann DH
    Ann Neurol; 1997 Aug; 42(2):230-5. PubMed ID: 9266734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between expression of Smac and Survivin and apoptosis of primary hepatocellular carcinoma.
    Bao ST; Gui SQ; Lin MS
    Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):580-3. PubMed ID: 17085346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular inhibitor of apoptosis (cIAP1) is down-regulated during retinal ganglion cell (RGC) maturation.
    Kisiswa L; Albon J; Morgan JE; Wride MA
    Exp Eye Res; 2010 Nov; 91(5):739-47. PubMed ID: 20831867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survivin expression and its relation with proliferation, apoptosis, and angiogenesis in brain gliomas.
    Zhen HN; Zhang X; Hu PZ; Yang TT; Fei Z; Zhang JN; Fu LA; He XS; Ma FC; Wang XL
    Cancer; 2005 Dec; 104(12):2775-83. PubMed ID: 16284993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequent HRK inactivation associated with low apoptotic index in secondary glioblastomas.
    Nakamura M; Ishida E; Shimada K; Nakase H; Sakaki T; Konishi N
    Acta Neuropathol; 2005 Oct; 110(4):402-10. PubMed ID: 16155764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitor of apoptosis proteins are regulated by tumour necrosis factor-alpha in malignant pleural mesothelioma.
    Gordon GJ; Mani M; Mukhopadhyay L; Dong L; Yeap BY; Sugarbaker DJ; Bueno R
    J Pathol; 2007 Mar; 211(4):439-46. PubMed ID: 17253597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No prognostic impact of survivin expression in glioblastoma.
    Preusser M; Gelpi E; Matej R; Marosi C; Dieckmann K; Rössler K; Budka H; Hainfellner JA
    Acta Neuropathol; 2005 May; 109(5):534-8. PubMed ID: 15843906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear expression of survivin is associated with improved survival in metastatic ovarian carcinoma.
    Kleinberg L; Flørenes VA; Silins I; Haug K; Trope CG; Nesland JM; Davidson B
    Cancer; 2007 Jan; 109(2):228-38. PubMed ID: 17167759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.